Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors
NCT07444775 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 148
Last updated 2026-03-03
Summary
The goal of this randomized, phase III trial is to to determine if Spatially Fractionated Lattice Radiotherapy (SFRT) known as LATTICE therapy, leads to a greater reduction in pain or discomfort compared with conventional Radiation Therapy (RT) in patients with large tumours. This is evaluated by assessing if a greater proportion of patients who receive RT with SFRT will have an improvement in pain/discomfort at 30 days defined using the International Consensus Pain Response (ICPR) compared with those treated with conventional RT.
Conditions
- Histopathologically or Cytologically Confirmed Solid Tumor Who Require Palliation Radiation Therapy to a Lesion ≥5cm
Interventions
- RADIATION
-
Conventional Radiation Therapy
Delivered using simple techniques and includes dose prescriptions of: 8Gy in 1 fraction, 20Gy in 5 fractions, and 30Gy in 10 fractions
- RADIATION
-
Spatially fractionated radiation therapy
LRT delivers ablative doses to discrete vertices within a tumor, forming a "lattice" while restricting the periphery of the tumor to a safe, low dose thereby minimizing radiation exposure to nearby OAR.
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-18
- Primary Completion
- 2028-01-31
- Completion
- 2028-01-31
Countries
- Canada
Study Locations
More Related Trials
-
Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
NCT04133415 ·Status: COMPLETED ·Phase: NA
-
LAttice Radiation Therapy for Large Lesions: Reggio Emilia Single-arm Phase II Trial
NCT07000162 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy
NCT00765570 ·Status: TERMINATED ·Phase: PHASE2
-
GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors
NCT02333110 ·Status: RECRUITING ·Phase: NA
-
Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction
NCT06362395 ·Status: RECRUITING ·Phase: PHASE3
-
Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors
NCT06390657 ·Status: WITHDRAWN
-
Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors
NCT04875871 ·Status: TERMINATED ·Phase: NA
-
Receiving Radiation Therapy in the MRgRT Research Facility
NCT02701712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma
NCT06980259 ·Status: RECRUITING ·Phase: NA
-
SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue
NCT06987370 ·Status: RECRUITING ·Phase: NA
-
Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy
NCT05831579 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
NCT06391242 ·Status: RECRUITING ·Phase: PHASE3
-
5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases
NCT01761929 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing SBRT to CRT in Patients With Spinal Metastases
NCT05589701 ·Status: RECRUITING
-
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
NCT03989596 ·Status: UNKNOWN ·Phase: PHASE2
-
Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously
NCT01543672 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT)
NCT01290562 ·Status: COMPLETED ·Phase: PHASE2
-
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
NCT00922974 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT07428148 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy for Spinal Metastases
NCT02800551 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Radiotherapy (SBRT) of Lung Metastasis
NCT01803542 ·Status: RECRUITING ·Phase: PHASE2
-
Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00771641 ·Status: COMPLETED ·Phase: PHASE3
-
High Precision RT For Soft-Tissue Sarcoma
NCT01389050 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord
NCT00631670 ·Status: COMPLETED ·Phase: NA
-
Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.
NCT04549246 ·Status: COMPLETED